• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Global Health

    US aid cuts overshadow HIV research advances

    The world is equipped with many of the tools that could help bring the HIV epidemic to an end, but U.S. funding cuts threaten their rollout to the people who need them the most.

    By Sara Jerving // 17 July 2025

    Tackling the HIV virus — which sneakily evades the immune system — has been an incredibly complex puzzle for the scientific community. It has required massive investments, expansive collaborations, and the dedication of some of the world’s sharpest minds — committed to the cause over decades.

    And now the world is equipped with many of the tools that could help bring this epidemic to an end — treatments, the ability to prevent transmission from mother to child, pre- and post-virus exposure prophylaxis, and a breakthrough six-month injectable prevention method, among other interventions.

    “The potential is in our grasp to end a pandemic and in the process, stop the needless [infections] and deaths that continue to impact millions each year,” said Dr. Beatriz Grinsztejn, president of the International Aids Society, during her organization’s conference in Kigali this week.

    This article is free to read - just register or sign in

    Access news, newsletters, events and more.

    Join usSign in

    More reading:

    ► Opinion: The US legacy in HIV is unraveling

    ► FDA approves new HIV prevention tool, though access questions linger

    ► Will infants finally have access to a highly effective HIV drug?

    • Funding
    • Democracy, Human Rights & Governance
    • Global Health
    • Trade & Policy
    • Research
    • National Institutes of Health (NIH) - United States
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Sara Jerving

      Sara Jervingsarajerving

      Sara Jerving is a Senior Reporter at Devex, where she covers global health. Her work has appeared in The New York Times, the Los Angeles Times, The Wall Street Journal, VICE News, and Bloomberg News among others. Sara holds a master's degree from Columbia University Graduate School of Journalism where she was a Lorana Sullivan fellow. She was a finalist for One World Media's Digital Media Award in 2021; a finalist for the Livingston Award for Young Journalists in 2018; and she was part of a VICE News Tonight on HBO team that received an Emmy nomination in 2018. She received the Philip Greer Memorial Award from Columbia University Graduate School of Journalism in 2014.

    Search for articles

    Related Stories

    Global healthUSAID funding cuts jeopardize breakthrough drugs and research

    USAID funding cuts jeopardize breakthrough drugs and research

    Global healthIn Malawi, the fight to get HIV services back on track post-USAID cuts

    In Malawi, the fight to get HIV services back on track post-USAID cuts

    Global HealthFDA approves new HIV prevention tool, though access questions linger

    FDA approves new HIV prevention tool, though access questions linger

    Global healthCuts to USAID-funded research another blow to global HIV response

    Cuts to USAID-funded research another blow to global HIV response

    Most Read

    • 1
      Opinion: AI-powered technologies can transform access to health care
    • 2
      Exclusive: A first look at the Trump administration's UNGA priorities
    • 3
      WHO anticipates losing some 600 staff in Geneva
    • 4
      Opinion: Resilient Futures — a world where young people can thrive
    • 5
      AIIB turns 10: Is there trouble ahead for the China-backed bank?
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement